Study and Treatment of Oral Squamous Cell Carcinoma—Insights and Perspectives-Reference-Cited by-同舟云学术

Study and Treatment of Oral Squamous Cell Carcinoma—Insights and Perspectives

Published:2023-10-13 Issue:20 Volume:15 Page:4968
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Hakim Samer George¹²^ORCID,Su Yu-Xiong (Richard)³^ORCID

Affiliation:

1. Department of Oral and Maxillofacial Surgery, Head and Neck Cancer Center, University Hospital Schleswig-Holstein (Campus Lübeck), D-23562 Luebeck, Germany

2. Department of Oral and Maxillofacial Surgery, Helios Medical Center, D-19055 Schwerin, Germany

3. Division of Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Hong Kong

Abstract

The prevalence of oral squamous cell carcinoma (OSCC) has increased in recent decades, and its impact on the health system has become a new aspect [...]

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/20/4968/pdf

Reference6 articles.

1. Mylly, M., Nissi, L., Huusko, T., Routila, J., Vaittinen, S., Irjala, H., Leivo, I., and Ventela, S. (2022). Epidemiological Study of p16 Incidence in Head and Neck Squamous Cell Carcinoma 2005–2015 in a Representative Northern European Population. Cancers, 14.

2. Berndt, A., Gassler, N., and Franz, M. (2022). Invasion-Associated Reorganization of Laminin 332 in Oral Squamous Cell Carcinomas: The Role of the Laminin gamma2 Chain in Tumor Biology, Diagnosis, and Therapy. Cancers, 14.

3. Nisar, S., Yousuf, P., Masoodi, T., Wani, N.A., Hashem, S., Singh, M., Sageena, G., Mishra, D., Kumar, R., and Haris, M. (2021). Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment. Int. J. Mol. Sci., 22.

4. The immune system and head and neck squamous cell carcinoma: From carcinogenesis to new therapeutic opportunities;Freiser;Immunol. Res.,2013

5. Pu, J.J., Hakim, S.G., Melville, J.C., and Su, Y.X. (2022). Current Trends in the Reconstruction and Rehabilitation of Jaw following Ablative Surgery. Cancers, 14.